Sorbitol Destroyed Intestinal Microfold Cells (M Cells) Development through Inhibition of PDE4-Mediated RANKL Expression

Xiang, Li; Pan, Wenxu; Chen, Huan; Du, Wenjun; Xie, Shuping; Liang, Xinhua; Yang, Fangying; Niu, Rongwei; Huang, Canxin; Luo, Minan; Xu, Yuxin; Geng, Lanlan; Gong, Sitang; Xu, Wanfu; Zhao, Junhong

doi:https://doi.org/10.1155/2024/7524314

Mediators of Inflammation

On this page

Abstract Introduction Materials and Methods Results Discussion Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Special Issue

Intracellular Crosstalk and Intercellular Communication in Inflammation-Associated Diseases

View this Special Issue

Research Article | Open Access

Volume 2024 | Article ID 7524314 | https://doi.org/10.1155/2024/7524314

Sorbitol Destroyed Intestinal Microfold Cells (M Cells) Development through Inhibition of PDE4-Mediated RANKL Expression

Li Xiang,^1,2Wenxu Pan,²Huan Chen,²Wenjun Du,²Shuping Xie,^1,2Xinhua Liang,²Fangying Yang,²Rongwei Niu,³Canxin Huang,⁴Minan Luo,⁵Yuxin Xu,^1,2and Lanlan Geng^1,2 et al.

Academic Editor: Jia Zhou

Received28 Oct 2023

Revised23 Mar 2024

Accepted10 Apr 2024

Published02 May 2024

Abstract

Objective. Microfold cells (M cells) are specific intestinal epithelial cells for monitoring and transcytosis of antigens, microorganisms, and pathogens in the intestine. However, the mechanism for M-cell development remained elusive. Materials and Methods. Real-time polymerase chain reaction, immunofluorescence, and western blotting were performed to analyze the effect of sorbitol-regulated M-cell differentiation in vivo and in vitro, and luciferase and chromatin Immunoprecipitation were used to reveal the mechanism through which sorbitol-modulated M-cell differentiation. Results. Herein, in comparison to the mannitol group (control group), we found that intestinal M-cell development was inhibited in response to sorbitol treatment as evidenced by impaired enteroids accompanying with decreased early differentiation marker Annexin 5, Marcksl1, Spib, sox8, and mature M-cell marker glycoprotein 2 expression, which was attributed to downregulation of receptor activator of nuclear factor kappa-В ligand (RANKL) expression in vivo and in vitro. Mechanically, in the M-cell model, sorbitol stimulation caused a significant upregulation of phosphodiesterase 4 (PDE4) phosphorylation, leading to decreased protein kinase A (PKA)/cAMP-response element binding protein (CREB) activation, which further resulted in CREB retention in cytosolic and attenuated CREB binds to RANKL promoter to inhibit RANKL expression. Interestingly, endogenous PKA interacted with CREB, and this interaction was destroyed by sorbitol stimulation. Most importantly, inhibition of PDE4 by dipyridamole could rescue the inhibitory effect of sorbitol on intestinal enteroids and M-cell differentiation and mature in vivo and in vitro. Conclusion. These findings suggested that sorbitol suppressed intestinal enteroids and M-cell differentiation and matured through PDE4-mediated RANKL expression; targeting to inhibit PDE4 was sufficient to induce M-cell development.

1. Introduction

Intestinal microfold (M) cells, playing a critical role in intestinal immunity, were a unique subset of intestinal epithelial cells (IECs) in the peyer’s patches, which allowed immune responses to occur in response to intestinal pathogens/antigens through sampling antigens/pathogens from the luminal surface to the subepithelium, gaining access to lamina propria for the purpose of infection and propagation and dissemination, such as murine norovirus and reovirus [1, 2], mammalian orthoreovirus [3], Salmonella typhimurium (S. typhimurium) [4, 5] and Candida albicans (C. albicans) [6, 7]. Moreover, M-cell deficient in Spib^−/− mice led to develop chronic and severe colitis with increased bacterial dissemination and attenuated commensal-specific Th1 and Th17 responses [8], suggesting the contribution of intestinal M cells to maintain intestinal hemostasis under physiological conditions. Despite the critical role of M cells in intestinal immunity, M-cell development and mature have not been fully addressed.

Up to date, limited studies have been available about M-cell development. M cells differentiated from leucine-rich repeat-containing G-protein-coupled receptor 5⁺ (Lgr5⁺) stem cells and regulated by both the receptor activator of the nuclear factor-κB ligand (RANKL) and transcription factor Spi-B [9–11]. Upon stimulation with RANKL, TNF receptor-associated factor 6 (TRAF6) activation triggered NF-κB pathway. The canonical RelA/p50 activation led to induce expression of early M-cell (immature) markers such as Marcks like 1 (MarcksL1) and chemokine (C–C motif) ligand 9 (CCL9), CCL20, whereas noncanonical RelB/p52 activation caused Spi-B and Sox8 transcription factors expression, which was essential to maturation of M cells (marker: glycoprotein 2: GP2) [12–14]. Moreover, Spi-B depletion or conditional knockout TRAF6 [13], SRY-Box transcription factor 8 (SOX8) [12], or S100A4 [15] could lead to decreased M cells numbers in vivo, while a novel M-cell–specific transcription factor polycomb repressive complexes 2 (PRC2)-regulated estrogen-related–receptor g (Esrrg) has been demonstrated to promote M-cell development and differentiation [14]. In addition to these findings, signaling pathways required for M-cell differentiation and mature remained elusive.

Alteration of metabolic reprograming in IECs is associated with many diseases, which is one of the key etiological factors of inflammatory bowel disease (IBD) and other digestive tract diseases [16–18]. The polyol pathway, an alternative glucose metabolism, was believed to play an important role in explaining the pathogenesis of complications in patients with end-stage diabetes [19]. The work from Huang et al. [20] and Yang et al. [21], respectively, showed that aldose reductase (AR) involved in intestinal epithelial cell differentiation and AR-mediated sorbitol in plasmacytes triggered metalloprotease 2 (MMP2) to cleave peptidoglycan recognition receptor LC (PGRP-LC) in fat body to initiate systemic innate immune communication in drosophila [21, 22], suggesting the critical role of polyol pathway in intestinal epithelial cell differentiation and immunity. Herein, in this work, we further addressed sorbitol treatment caused a significant downregulation of early M-cell differentiation marker expression, including SOX8 and spi-B, and mature marker GP2 expression, leading to inhibit M-cell development, which was attributed to decreased RANKL expression in vivo and in vitro. Further results showed that sorbitol triggered phosphorylation of phosphodiesterase 4 (PDE4) in the M-cell model, leading to decreased protein kinase A (PKA)/cAMP-response element binding protein (CREB) signaling and nuclear translocation of CREB, which attenuated CREB binds to RANKL promoter, suppressing transcriptional activation of RANKL. What is more, inhibition of PDE4 could reverse the inhibitory effect of sorbitol on M-cell development in vivo and in vitro. Taken together, our study has extended the function of sorbitol and revealed a novel mechanism underlying M-cell development.

2. Materials and Methods

2.1. Reagents and Antibodies

Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12) (GIBCO, C11330500BT) and fetal bovine serum (FBS) (GIBCO, 10099141C) were purchased from Life Technologies (Carlsbad, CA, USA); IntestiCult™ Organoid Growth Medium (mouse) (06005) and gentle cell dissociation reagent (07174) were purchased from STEMCELL Technologies, CryoStor CS10 (07930) was from Biolife Soultions. Corning® Matrigel® growth factor reduced (GFR) basement membrane matrix (356231) was from Corning. Phenylmethanesulfonyl fluoride (PMSF, P0100) and protease inhibitor cocktail (PIC, P6730) were from Solarbio (Beijing, China); Beyozol RNA Isolation Kit (R0011) was purchased from Beyotime Biotechnology (Shanghai, China); All-in-One First-Strand cDNA Synthesis Kit (QP006) and All-in-One quantitative polymerase chain reaction (qPCR) Mix (QP005) were obtained from GeneCopoeia (Rockville, MD, USA). D-Sorbitol (HY-B0400), D-Mannitol (HY-N0378), and Dipyridamole (DIP, HY-B0312) were from MedChemExpress (NJ, USA). RANKL monoclonal antibody (Proteintech, 66610-1-Ig); phospho-PDE4 (Immunoway, YP0668) was from Immunoway (Jiangsu, China), PKACA (Proteintech, 67491-1-Ig), CREB1 polyclonal antibody (Proteintech, 12208-1-AP); Phospho-CREB1 (Ser133) polyclonal antibody (Proteintech, 28792-1-AP), Lamin A/C polyclonal antibody (Proteintech, 10298-1-AP) and α-tubulin monoclonal antibody (Proteintech, 66031-1-Ig) were from Proteintech; phospho-PKA (Thr197) (CST, 5661) was from cell signaling technology (Danvers, MA, USA); peroxidase-affiniPure goat anti-rabbit IgG (H + L) (111-035-003) and peroxidase-affiniPure goat anti-mouse IgG (H + L) (115-035-003)were purchased from Jackson. Alexa-488- and 594-conjugated secondary antibodies were from Immunoway (Beijing, China).

2.2. Cell Lines, M-Cell Model, and Treatment

As described in a previous study [23], Raji B and CaCO₂ cells were from the American Type Culture Collection and cultured in RPMI1640 and DMEM, respectively, supplemented with 10% FBS according to the manufacturer’s recommendations. For the M-cell model, the CaCO₂/Raji B coculture system was established as follows: 4 × 10⁵ CaCO₂ cells were digested and seeded into the inserts in a 6-well plate, and 4 × 10⁷ Raji B cells were placed into the bottom of the insert. TEER was measured every 2 days, starting from day 0 to day 21, to monitor cell differentiation. The coculture was established for 4 days after CaCO₂ cells was maintained for 3 weeks, and the medium changed every day. For treatment, mannitol and sorbitol were used at a final concentration of 100 mM; DIP was used at a final concentration of 6 μM.

2.3. Crypt Isolation, Intestinal Organoid Culture, and Treatment

Small intestines were isolated from C57BL6 and immersed into ice DPBS (STEMCELL, 37350) to cut into 1–2 mm pieces, followed by suspension with GCDR (STEMCELL, 07174). Centrifugation at 290 g for 5 min was performed after incubation on a shaker at 20 rpm for 15 min at room temperature; the supernatant was removed after gravity settling for 30 s. The tissue fragment was resuspended with 10 mL cold phosphate buffer solution (PBS) containing 0.1% BSA and subjected by a 70 μm cell strainer (Corning®, 352350) to collect the filtrate in a clean 50 mL tube to remove the tissue fragments. The crypts were resuspended with intestiCult™ medium (STEMCELL, 06005) containing 50% matrigel® (Corning®, 356231) after centrifugation at 200 g for 5 min at 4°C and seeded in the center of 24-plate (Corning®; 3526) to rest for 20 min until the Matrigel forms a dome, 750 μL intestiCult™ medium were added into well to culture for 7–10 days in incubators at 37°C and 5% CO₂ with changes of medium every 2–3 days. Enteroids were imaged daily under a microscope.

For treatment, the control group was treated with mannitol (100 mM) to rule out osmotic pressure and the sorbitol group was treated with sorbitol (100 mM), the treatment group was stimulated with sorbitol combined with 8 μM RANKL or 6 μM DIP. Medium was replaced every 2 days, and organoids were cultured for 7 days. On the 2nd, 4th, and 7th day of culture, we observed the effect of indicated treatments on the apparent changes of organoids during differentiation and maturation. On the 7th day of organoid culture, the supernatant was collected to measure RANKL expression in the supernatant. The total RNA level isolated from organoids was collected to detect relative gene expression, or the organoids were harvested to fix to prepare for immunofluorescence (IF) analysis.

2.4. RNA Extraction and qRT-PCR

As described in our previous study, total RNA from the indicated treatment was extracted and converted into cDNA according to the Beyozol RNA Isolation Kit and the All-in-One™ first-strand cDNA synthesis kit (Genecopoeia™, FulenGen), respectively. Quantitative PCR (qPCR) was carried out to detect gene expression using the All-in-One™ qPCR mix (Genecopoeia™, FulenGen) according to the manufacturer’s instructions. Primer sequences used in this study were listed as followed: GP2: forward: 5^′-AATGTGCGGGAGAATGGTGT-3^′ and reverse: 5^′-TCTGAGCACTGGTTGACACT-3^′; spib: forward: 5^′-ATCACAGCTGCCACCATCTC-3^′ and reverse: 5^′-ACAGCTTAAGTGTGGGCCAT-3^′; Marcksl1: forward:5^′-GGAGAATGGCCACGTGAGAA-3^′ and reverse: 5^′-TCGATGGCATCACCAGTAGC-3^′; SOX8: forward: 5^′-ATCATTGGGCCAGGCATTGA-3^′ and reverse: 5^′-GTTGGGGAGGCTCTCCTTTC-3^′; ANXA5: forward: 5^′-GACCGACAGCATCATGGCTA-3^′ and reverse: 5^′-AGCATTGCTTCGGGATGTCA-3^′; GAPDH: forward: 5^′-TGTGTCCGTCGTGGATCTG-3^′ and reverse: 5^′-CCTGCTTCACCACCTTCTTGA-3^′.

2.5. IF

As described in the previous studies [24, 25], after dewaxing and dehydration, the slide of intestinal organoid was subjected from antigen retrieval and blocked with goat serum for 30 min. The slips were incubated with the primary antibody overnight at 4°C, followed by incubation with Alexa-488- or Alexa 594-conjugated secondary antibodies for 1 hr at room temperature. The coverslips were mounted onto glass slides with prolonged gold antifade reagent with DAPI, and stained cells were imaged under a laser scanning confocal fluorescent microscope.

2.6. Enzyme-Linked Immunosorbent Assay (ELISA)

RANKL level in the supernatant of the M-cell model in response to mannitol and sorbitol treatment was measured using Mouse RANKL ELISA Kit (Cloud Clone Corp. TX; SEA855Mu) according to manufactory instruction. Absorbances were measured at a wavelength of 450 nm, subtracting the values measured at 570 nm, using a microplate reader.

2.7. Western Blotting (WB) and Immunoprecipitation (IP)

As described in our work [20, 25], for IP, cells were lysed in ice-cold buffer composed of 50 mmol/L Tris–HCl (pH 7.4), 150 mmol/L NaCl, 0.1% NP-40 and protease inhibitors, followed by incubation overnight with anti-PKA, and further incubation was performed with protein A/G beads for 1 hr at 4°C. Beads were washed five times with low-salt lysis buffer, and immunoprecipitates were eluted for sodium dodecyl sulfate–polyacrylamide gel electrophoresis. For the immunoblotting, proteins were transferred into nitrocellulose (NC) membranes to incubate with primary antibodies overnight after blocking with 3% milk in PBST; the secondary antibodies were added to incubate for a further 1 hr at room temperature, and proteins were detected using an enhanced chemiluminescence (Perkin Elmer).

2.8. Luciferase Assay

As described in our work [25], the reporter plasmid containing RANKL promoter was transfected into HT-29 cells with internal control pGL4.74 for 24 hr, and mannitol and sorbitol were used to treat for another 24 hr, the relative luciferase unit was measured according to dual-luciferase reporter assay system (Promega).

2.9. Chromatin Immunoprecipitation (ChIP)

As described in previous studies [26, 27], CaCO₂ cells were grown up to 80% confluence, the cell was treated with serum-free medium for 24 hr and stimulated with Mannitol or Sorbitol for another 1 hr, respectively, and the ChIP was performed according to the manufacturer’s protocol to analyze the effect of sorbitol on CREB binds to RANKL promoter. Quantitative PCR of co-immunoprecipitated genomic DNA fragments was performed with specific primers was synthesized from thermolife.

2.10. Ethical Approval of Animal Studies

About 6–8 weeks, C57BL/6 mice were obtained from Southern Medical Univeristy to isolate crypt isolation for intestinal organoid experiments, which were housed in individually ventilated cages in a barrier facility proactive in environmental enrichment under specific pathogen-free conditions in line with European Union regulations. All experimental animal procedures were approved by the Institutional Animal Committee of Southern Medical University (SMUL2021156).

2.11. In Vivo Experiment

About 6–8 weeks, C57BL/6 mice were randomly grouped into three groups: mannitol group, sorbitol group, and sorbitol group received DIP treatment. In detail, mice received with mannitol or sorbitol alone dissolved in H₂O at concertation of 100 mM for 1 week and combined with DIP for another 1 week. This 2-week cycle was repeated for 3 times. Mice were killed for intestine isolation to analyze M-cell differentiation.

2.12. Statistics Analysis

The data were displayed as mean ± s.e.m. and statistical analysis was conducted with GraphPad Prism nine software. The difference in qPCR assay was analyzed by one sample t test, and one-way ANOVA was used to determine the difference in RANKL level through ELISA assay. Two ANOVAs were used to analyze the difference in luciferase assays. A p value less than 0.05 was significant.

3. Results

3.1. Sorbitol-Inhibited M-Cell Development In Vitro

To further determine the potential role of sorbitol on M-cell development, intestinal organoid combined with IF and qPCR was used to identify the relative gene expression changes involved in the differentiation and maturity of M cells. As shown in Figure 1(a), mannitol was employed as a control group to rule out osmotic pressure, and sorbitol treatment led to a significantly impaired intestinal organoid. qPCR results from intestinal organoid further showed that in comparison with the mannitol group, downregulation of genes involved in M-cell differentiation, including ANXA5, Spi-B, SOX8, and Marcksl1 were obviously observed in response to sorbitol stimulation. In addition, Mature M cells marker GP2 was largely inhibited by sorbitol (Figure 1(b)). Further analysis showed that impaired intestinal organoid was observed in response to sorbitol stimulation in a dose-dependent manner (Figure 1(c)). What is more, the apoptosis-related protein expressions, including caspase3 and Bax, were increased, while BCL-2 and ki67 expressions were decreased in response to sorbitol treatment (Figure S1(a)); in addition, caspase3 mRNA level expression was increased in response to sorbitol treatment (Figure S1(b)). These findings suggested that sorbitol inhibited the development of intestinal M cells.

(a)

(b)

(c)

Figure 1

Sorbitol suppressed M-cell differentiation: (a) intestinal organoids were analyzed in response to 100 mM mannitol and 100 mM sorbitol. The representative image of intestinal organoids was captured to analyze the effect of sorbitol on M-cell differentiation; (b) the total RNA was extracted from the indicated group described in (a), and real-time PCR was employed to detect related gene expression involved in M-cell differentiation, including GP2, ANXA5, spi-B, SOX8, and Marckl1. Data presented as the mean ± s.e.m. of three independent experiments and were analyzed by one sample t test, , ; (c) the representative image of intestinal organoids was imaged in response to various concertation of sorbitol. Bar: 75 μm, data presented as the mean ± s.e.m. were analyzed by one ANOVA, .

3.2. Sorbitol-Suppressed M-Cell Differentiation through RANKL

The above results implied that sorbitol played an important role in regulating intestinal M-cell development. RANKL has been reported to induce mature marker GP2 expression during M-cell differentiation [28, 29], which focused us to explore whether sorbitol-regulated M-cell development is dependent on RANKL. As shown in Figures 2(a) and 2(b), in comparison with mannitol, both the results from WB and ELISA have shown that RANKL was largely decreased in intestinal organoid treated with sorbitol at the protein level in the M-cell model. What’s more, the addition of recombinant of RANKL could reverse the impaired effect of sorbitol on intestinal organoid (Figure 2(c)). Taken together, these results suggested sorbitol destroyed intestinal organoids through RANKL.

(a)

(b)

(c)

Figure 2

Sorbitol regulated M-cell differentiation through PDE4/PKA/CREB signaling-mediated RANKL: (a) after establishing M-cell model, the total protein was extracted from M-cell model treated with 100 mM mannitol or 100 mM sorbitol for 24 hr, western blotting was used to detect RANKL; (b) the M cells was established and treated described in (a), and the concentration of RANKL level in supernatant was measured in indicated group through ELISA assay. Data presented as the mean ± s.e.m. of three independent experiments and were analyzed by t test, ; (c) intestinal organoids culture was performed to visualize the effect of PDE4 inhibition by DIP on sorbitol-mediated M-cell development. Bar: 50 μm. Data presented as the mean ± s.e.m. and were analyzed by one ANOVA, , .

3.3. CREB was Required for Sorbitol-Mediated RANKL Expression

The binding of CREB to the RANKL promoter and subsequent transcription activation has been addressed in a large number of studies [30, 31], which focused us to seek whether sorbitol-regulated RANKL expression is dependent on CREB. As shown in Figure 3(a), overexpression of CREB significantly enhanced the relative luminescence unit (RLU) of RANKL in HT-29 cells transfected with a reporter gene containing RANKL promoter and pGL4.74 in the mannitol group, while sorbitol treatment largely blocked the promotion of CREB on RANKL luminescence. Moreover, ChIP revealed that in comparison with mannitol, sorbitol stimulation led to a significant downregulation binding of CREB to the RANKL promoter (Figure 3(b)). What is more, ectopic expression of CREB in CaCO₂ cells largely rescued the inhibitory effect of sorbitol on RANKL expression and secretion (Figure 3(c)). These results suggested that CREB is required for sorbitol-derived RANKL expression.

(a)

(b)

(c)

Figure 3

CREB is critical for sorbitol-mediated RANKL expression: (a) reporter gene containing RANKL promoter was transfected into CaCO₂ cells combined with pGL4.74 plasmid for 24 hr, CaCO₂ cell was treated with 100 mM mannitol and 100 mM sorbitol for further 24 hr, the relative luciferase unit was detected using dual-luciferase reporter assay system. Data presented as the mean ± s.e.m. of three independent experiments and were analyzed by two ANOVA, , ; (b) after serum-free for 24 hr, CaCO₂ cells were stimulated for 1 hr, and the whole cell was fixed and lysed to incubate with an anti-CREB antibody, the chromosome fragments binding to CREB were amplified and quantified by real-time PCR with RANKL promoter primer. Data presented as the mean ± s.e.m. of three independent experiments and were analyzed by two ANOVA, ; (c) ELISA was employed to detect RANKL level in indicated group in CaCO₂ cells, data presented as the mean ± s.e.m. of five independent experiments and were analyzed by one ANOVA, .

3.4. Sorbitol-Modulated PDE4/PKA/CREB Cascade Signaling

CREB is the critical transcript factor in cAMP signaling; targeting to inhibit PDE4 by dipyridamole (DIP) could enrich CD8⁺CD39⁺T cells abundance and enhance CDX2 in IECs, alleviating intestinal inflammation and inducing mucosa healing [32, 33]. The M-cell model was used to analyze the potential changes of PDE4/PKA/CREB signaling in response to sorbitol stimulation [34, 35]. The results from WB demonstrated that sorbitol treatment led to a significant retention of cytosolic CREB, which was attributed to impaired interaction between PKA and CREB caused by sorbitol (Figure 4(a)). The work further showed that sorbitol triggered activation of PDE4, leading to inhibited phosphorylation of PKA (Thr197) and CREB (Ser133) confirmed by the immunoblotting from the M-cell model, despite no significant difference was observed in the baseline of PDE4/PKA/CREB (Figure 2(b)). What is more, inhibition of PDE4 by DIP largely blocked the effect of sorbitol on PDE4/PKA/CREB signaling, leading to increased RANKL secretion (Figure 4(b)). Most importantly, intestinal organoids have further confirmed that inhibition of PDE4 by DIP could reverse the sorbitol on intestinal organoids development, leading to enhanced GP2 and RANKL expression (Figures 4(c) and 4(d)). Taken together, these findings suggested that sorbitol suppressed RANKL expression through modulating PDE4/PKA/CREB signaling.

(a)

(b)

(c)

(d)

Figure 4

Sorbitol modulated PDE4/PKA/CREB signaling: (a) upper panel: CaCO₂ cells were serum starved for 24 hr and stimulated with mannitol, sorbitol, and sorbitol+DIP for further 1 hr. Cell fraction was isolated and levels of cytosolic CREB were detected by western blotting. α-Tubulin and lamin A/C were used as internal controls for the cytosolic and nuclear fractions, respectively. Bottom panel: CaCO₂ cells were confluence, serum starved for 24 hr, then stimulated with 100 mM mannitol or sorbitol combined with or without DIP for 1 hr. Immunoprecipitation was performed with antibodies targeting endogenous PKA and immunoblotting was used to detect CREB; (b) after establishing M-cell model, the total protein was extracted from M-cell model treated with 100 mM mannitol or 100 mM sorbitol and 100 mM sorbitol + DIP for 24 hr, western blotting was used to detect RANKL, baseline and phosphorylation of PDE4/PKA/CREB. α-tubulin was served as an internal control; (c) intestinal organoids culture was performed to analyze the mannitol, sorbitol, sorbitol + DIP on differentiation. Data presented as the mean ± s.e.m. of five independent experiments and were analyzed by one ANOVA, ; (d) IF was used to detect M cells mature marker GP2 expression and RANKL expression in the indicated group.

3.5. DIP Improved Sorbitol-Mediated M-Cell Differentiation Inhibition In Vivo

To confirm whether inhibition of PDE4 could rescue the effect of sorbitol on M-cell differentiation in vivo. The in vivo model was established as described in Yang et al. [36] work with brief modification. As shown in Figure 5(a), mice were fed with water supplemented with 2% (wt/vol) mannitol or sorbitol for 7 days and combined with PDE4 inhibitor DIP treatment for another week. This 2-week treatment was repeated for three cycles. On the last day, the intestine was isolated for analysis of M cells after mice were euthanized. As expected, the results showed that, in comparison with mannitol group, sorbitol treatment led to a significant inhibition of mature M cells labeled with GP2, while DIP treatment reversed the inhibitory effect of sorbitol on M cells development (Figure 5(b)). Collectively, this work suggested that targeting PDE4 by DIP could be a promising strategy to induce M-cell differentiation.

(a)

(b)

4. Discussion

Metabolites or metabolic reprograming is critical for cell fate. Up to now, to our best knowledge, there are no available reports about the function of metabolites or metabolic reprograming on intestinal M-cell development. In this work, we demonstrated sorbitol, the production of the polyol pathway, and derived intestinal organoid damage through the reduction of RANKL expression. Mechanically, activation of PDE4 was obviously observed in the M-cell model after treatment with sorbitol, which further led to inhibited phosphorylation of PKA/CREB, reducing CREB nuclear translocation and decreasing the binding of CREB to RANKL promoter. What is more, endogenous PKA interacted with CREB, and this interaction was disrupted by sorbitol stimulation. Most importantly, inhibition of PDE4 by DIP could overcome the inhibitory effect of sorbitol on intestinal M-cell development in vivo and in vitro. These findings extended the role of sorbitol in M-cell differentiation and suggested targeting to inhibit PDE4 by dipyridamole, which is a promising strategy for intestinal M-cell development.

The polyol pathway, the conversion of glucose into sorbitol, is almost silent, which is activated in hyperglycemic conditions and has deleterious effects on human health [19, 37]. In addition, the polyol pathway is necessary for ChREBP nuclear localization in hepatocytes and glucose tolerance in mice, and long-term uptake of sorbitol could induce a significant change in the composition of the gut microbiome [38]. The further work showed that sorbitol could induce an upregulation of Aquaporins 7 expression in a time-dependent manner [39] and apoptosis [40, 41]. What is more, sorbitol was found to be able to relay gut-fat body immunological communication (GFIC) by activation of metalloprotease 2, which further cleaved PGRP-LC to activate immune deficiency response in fat bodies [21]. In this work, we further extended the novel role of sorbitol in gastroenterology that sorbitol suppressed intestinal M-cell differentiation and matured through RANK in vivo and in vitro, which was attributed to the activation of PDE4. Inhibition of PDE4B by DIP could rescue the inhibitory effect of sorbitol on M-cell development. However, in addition to M cells, the further work is required to address the potential function of sorbitol in other intestinal epithelial cell development, including goblet cells, paneth cells, and tuft cells.

The classical second messenger cAMP pathway has been confirmed to be essential for a variety of physiological functions, including mitochondrial biology, lipid metabolism, ischemia, and inflammation [42]. Recent work has demonstrated that inhibition of PDE4 by apremilast modulated cAMP-predominant PKA-CREB signaling ameliorated the clinical symptoms of chronic UC as evidenced by improvement in mucosal ulcerations, tissue fibrosis, and inflammatory infiltrations [43, 44]. Our previous work has suggested that PDE4 inhibition could lead to CDX2 expression, leading to intestinal epithelial cell differentiation [33]. In this work, inhibition of PDE4 could alleviate sorbitol-induced impaired M-cell development. These works suggested that PDE4 activity is critical for M-cell development. However, the further work was required to address how sorbitol activated PDE4 phosphorylation, the receptor of sorbitol is urgently to be identified, and whether the sorbitol receptor involved in M-cell development remained elusive.

Taken together, these findings extended the role of sorbitol and established the mechanism through which sorbitol regulated M-cell development by activation of PDE4, which could be a theoretical foundation for DIP used in maintaining mucosal immunity function.

Abbreviations

ANXA5:	Annexin 5
AR:	Aldose reductase
AQP7:	Aquaporins 7
CREB:	cAMP-response element-binding protein
CCL:	Chemokine (C–C motif) ligand
ChIP:	Chromatin immunoprecipitation
DMEM:	Dulbecco’s modified Eagle medium
DIP:	Dipyridamole
DMEM:	Dulbecco’s modified Eagle’s medium/F12
Esrrg:	Estrogen-related receptor g
FBS:	Fetal bovine serum
GP2:	Glycoprotein 2
GFIC:	Gut-fat body immunological communication
IF:	Immunofluorescence
IBD:	Inflammatory bowel disease
IECs:	Intestinal epithelial cells
Lgr5:	Leucine-rich repeat-containing G-protein-coupled receptor 5
M cells:	Microfold cells
MMP2:	Metalloprotease 2
MARCKSL1:	MARCKS-like protein 1
PRC2:	Polycomb repressive complexes 2
PKA:	Protein kinase A
PDE4:	Phosphodiesterase 4
PBS:	Phosphate Buffer solution
PMSF:	Phenylmethanesulfonyl fluoride
PGRP-LC:	Peptidoglycan recognition receptor LC
qPCR:	Quantitative polymerase chain reaction
RANKL:	Receptor activator of nuclear factor kappa-В ligand
SOX8:	SRY-Box transcription factor 8
SDS–PAGE:	Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
TRAF6:	TNF receptor-associated factor 6
TBST:	Tris-buffered saline tween-20
WB:	Western blotting.

Data Availability

The datasets generated during and/or analyses during the current study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Conceptualization was done by Wanfu Xu, Sitang Gong, Lanlan Geng, and Junhong Zhao; methodology was done by Li Xiang, Wenxu Pan, Huan Chen, Canxin Huang, Xinhua Liang, and Wenjun Du; investigation was done by Li Xiang, Shuping Xie, Minan Luo, Yuxin Xu, Rongwei Niu, Fangying Yang, Wenjun Du, Wenxu Pan, Xinhua Liang, Huan Chen, and Junhong Zhao; resources were provided by Junhong Zhao and Li Xiang; data processing was done by Li Xiang, Huan Chen, Shuping Xie, Rongwei Niu, Wenxu Pan, and Wanfu Xu; curation and visualization were done by Li Xiang, Junhong Zhao, and Wanfu Xu; writing—original draft was done by Li Xiang, Wenxu Pan, and Wanfu Xu; manuscript revision and editing were done by Li Xiang and Wanfu Xu; supervision was done by Junhong Zhao; funding acquisition was made by Huan Chen, Lanlan Geng, Sitang Gong, Wanfu Xu, and ZJH. Li Xiang, Wenxu Pan, and Huan Chen contributed equally to this work.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (no. 82200607), Guangdong Basic and Applied Basic Research Foundation (nos. 2020A1515110109, 2021A1515012194, and 2023A1515030064), basic and applied research projects of Guangzhou Municipal Science and Technology Project (nos. 202102010321, 202201020631, 2024A03J1085, and 2024A04J4257), Guangzhou Medical Key Disciplines and Specialties (no. 011006003). Guangzhou Key Laboratory of Pediatric Inflammatory Bowel Disease (2023A03J0866), Clinical Doctor Start-Up Funding (2023BS030), Accurate Diagnosis, Treatment and Prevention Strategies for Digestive System Diseases Related to Diarrhea in Children (2023YFC2706500), Guangzhou Clinical Medicine Institute of Pediatric Digestive (011009003), Plan on Enhancing Scientific Research in GMU (02-410-2302154XM).

Supplementary Materials

Figure S1: the effect of sorbitol on M-cell apoptosis. (Supplementary Materials)

References

M. B. Gonzalez-Hernandez, T. Liu, H. C. Payne et al., “Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells,” Journal of Virology, vol. 88, no. 12, pp. 6934–6943, 2014.
View at: Publisher Site | Google Scholar
R. S. Sauls and B. N. Taylor, Histology, M Cell, StatPearls Publishing, Treasure Island (FL), 2024.
T. Tong, Y. Qi, L. D. Bussiere et al., “Transport of artificial virus-like nanocarriers through intestinal monolayers via microfold cells,” Nanoscale, vol. 12, no. 30, pp. 16339–16347, 2020.
View at: Publisher Site | Google Scholar
N. Y. Lai, M. A. Musser, F. A. Pinho-Ribeiro et al., “Gut-innervating nociceptor neurons regulate peyer’s patch microfold cells and SFB levels to mediate Salmonella host defense,” Cell, vol. 180, no. 1, pp. 33–49.e22, 2020.
View at: Publisher Site | Google Scholar
A. M. Gonzales, S. Wilde, and K. L. Roland, “New insights into the roles of long polar fimbriae and Stg fimbriae in Salmonella interactions with enterocytes and M cells,” Infection and Immunity, vol. 85, no. 9, 2017.
View at: Publisher Site | Google Scholar
Y. Tong and J. Tang, “Candida albicans infection and intestinal immunity,” Microbiological Research, vol. 198, pp. 27–35, 2017.
View at: Publisher Site | Google Scholar
S. Albac, A. Schmitz, C. Lopez-Alayon et al., “Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro,” Cellular Microbiology, vol. 18, no. 2, pp. 195–210, 2016.
View at: Publisher Site | Google Scholar
Y. Nakamura, H. Mimuro, J. Kunisawa et al., “Microfold cell-dependent antigen transport alleviates infectious colitis by inducing antigen-specific cellular immunity,” Mucosal Immunology, vol. 13, no. 4, pp. 679–690, 2020.
View at: Publisher Site | Google Scholar
W. de Lau, P. Kujala, K. Schneeberger et al., “Peyer’s patch M cells derived from Lgr5⁺ stem cells require SpiB and are induced by RankL in cultured “Miniguts”,” Molecular and Cellular Biology, vol. 32, no. 18, pp. 3639–3647, 2012.
View at: Publisher Site | Google Scholar
R. T. Taylor, S. R. Patel, E. Lin et al., “Lymphotoxin-independent expression of TNF-related activation-induced cytokine by stromal cells in cryptopatches, isolated lymphoid follicles, and Peyer’s patches,” The Journal of Immunology, vol. 178, no. 9, pp. 5659–5667, 2007.
View at: Publisher Site | Google Scholar
S. Sato, S. Kaneto, N. Shibata et al., “Transcription factor Spi-B–dependent and –independent pathways for the development of Peyer’s patch M cells,” Mucosal Immunology, vol. 6, no. 4, pp. 838–846, 2013.
View at: Publisher Site | Google Scholar
S. Kimura, N. Kobayashi, Y. Nakamura et al., “Sox8 is essential for M cell maturation to accelerate IgA response at the early stage after weaning in mice,” Journal of Experimental Medicine, vol. 216, no. 4, pp. 831–846, 2019.
View at: Publisher Site | Google Scholar
T. Kanaya, S. Sakakibara, T. Jinnohara et al., “Development of intestinal M cells and follicle-associated epithelium is regulated by TRAF6-mediated NF-κB signaling,” Journal of Experimental Medicine, vol. 215, no. 2, pp. 501–519, 2018.
View at: Publisher Site | Google Scholar
J. J. George, M. Oittinen, L. Martin-Diaz et al., “Polycomb repressive complex 2 regulates genes necessary for intestinal microfold cell (M cell) development,” Cellular and Molecular Gastroenterology and Hepatology, vol. 12, no. 3, pp. 873–889, 2021.
View at: Publisher Site | Google Scholar
K. Kunimura, D. Sakata, X. Tun et al., “S100A4 protein is essential for the development of mature microfold cells in peyer’s patches,” Cell Reports, vol. 29, no. 9, pp. 2823–2834.e7, 2019.
View at: Publisher Site | Google Scholar
X. Pan, Q. Zhu, L.-L. Pan, and J. Sun, “Macrophage immunometabolism in inflammatory bowel diseases: from pathogenesis to therapy,” Pharmacology & Therapeutics, vol. 238, Article ID 108176, 2022.
View at: Publisher Site | Google Scholar
V. Zaiatz Bittencourt, F. Jones, G. Doherty, and E. J. Ryan, “Targeting immune cell metabolism in the treatment of inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 27, no. 10, pp. 1684–1693, 2021.
View at: Publisher Site | Google Scholar
Y.-H. Liu, Y. Ding, C.-C. Gao, L.-S. Li, Y.-X. Wang, and J.-D. Xu, “Functional macrophages and gastrointestinal disorders,” World Journal of Gastroenterology, vol. 24, no. 11, pp. 1181–1195, 2018.
View at: Publisher Site | Google Scholar
H. Sano, A. Nakamura, M. Yamane et al., “The polyol pathway is an evolutionarily conserved system for sensing glucose uptake,” PLoS Biology, vol. 20, no. 6, Article ID e3001678, 2022.
View at: Publisher Site | Google Scholar
L. Huang, X. Tang, F. Y. Yang et al., “Shikonin contributes to intestinal epithelial cell differentiation through PKM2/NRF2-mediated Polyol pathway,” Pharmacological Research - Modern Chinese Medicine, vol. 1, Article ID 100004, 2021.
View at: Publisher Site | Google Scholar
S. Yang, Y. Zhao, J. Yu et al., “Sugar alcohols of polyol pathway serve as alarmins to mediate local-systemic innate immune communication in Drosophila,” Cell Host & Microbe, vol. 26, no. 2, pp. 240–251.e8, 2019.
View at: Publisher Site | Google Scholar
B. Lemaitre and J. Hoffmann, “The host defense of Drosophila melanogaster,” Annual Review of Immunology, vol. 25, pp. 697–743, 2007.
View at: Publisher Site | Google Scholar
V. C. Ude, D. M. Brown, V. Stone, and H. J. Johnston, “Time dependent impact of copper oxide nanomaterials on the expression of genes associated with oxidative stress, metal binding, inflammation and mucus secretion in single and co-culture intestinal in vitro models,” Toxicol In Vitro, vol. 74, Article ID 105161, 2021.
View at: Publisher Site | Google Scholar
Y. Wang, X. Zhou, K. Zou et al., “Monocarboxylate transporter 4 triggered cell pyroptosis to aggravate intestinal inflammation in inflammatory bowel disease,” Frontiers in Immunology, vol. 12, Article ID 644862, 2021.
View at: Publisher Site | Google Scholar
X. Liang, W. Du, L. Huang et al., “Helicobacter pylori promotes gastric intestinal metaplasia through activation of IRF3-mediated kynurenine pathway,” Cell Communication and Signaling, vol. 21, Article ID 141, 2023.
View at: Publisher Site | Google Scholar
W. Xu, Z. Zhang, K. Zou et al., “MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis,” Cell Death & Disease, vol. 8, no. 5, Article ID e2761, 2017.
View at: Publisher Site | Google Scholar
S. Zhang, W. Xu, H. Wang et al., “Inhibition of CREB-mediated ZO-1 and activation of NF-κB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function,” Cell Proliferation, vol. 52, no. 6, Article ID e12673, 2019.
View at: Publisher Site | Google Scholar
S. Kimura, Y. Nakamura, N. Kobayashi et al., “Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity,” Nature Communications, vol. 11, Article ID 234, 2020.
View at: Publisher Site | Google Scholar
Y. Li, S. Yang, X. Huang et al., “MyD88 mediates colitis- and RANKL-induced microfold cell differentiation,” Veterinary Sciences, vol. 9, no. 1, Article ID 6, 2022.
View at: Publisher Site | Google Scholar
H.-J. Park, K. Baek, J.-H. Baek, and H.-R. Kim, “TNFα increases RANKL expression via PGE₂-induced activation of NFATc1,” International Journal of Molecular Sciences, vol. 18, no. 3, Article ID 495, 2017.
View at: Publisher Site | Google Scholar
H. J. Park, K. Baek, J. H. Baek, and H. R. Kim, “The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells,” Journal of Cellular Physiology, vol. 230, no. 3, pp. 667–679, 2015.
View at: Publisher Site | Google Scholar
B. Huang, Z. Chen, L. Geng et al., “Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways,” Cell, vol. 179, no. 5, pp. 1160–1176.e24, 2019.
View at: Publisher Site | Google Scholar
W. Pan, L. Xiang, X. Liang et al., “Vitronectin destroyed intestinal epithelial cell differentiation through activation of PDE4-mediated ferroptosis in inflammatory bowel disease,” Mediators of Inflammation, vol. 2023, Article ID 6623329, 16 pages, 2023.
View at: Publisher Site | Google Scholar
C. Schimpel, B. Teubl, M. Absenger et al., “Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles,” Molecular Pharmaceutics, vol. 11, no. 3, pp. 808–818, 2014.
View at: Publisher Site | Google Scholar
B. Lasa-Saracíbar, M. Guada, V. Sebastián, and M. Blanco-Prieto, “In vitro intestinal co-culture cell model to evaluate intestinal absorption of edelfosine lipid nanoparticles,” Current Topics in Medicinal Chemistry, vol. 14, no. 9, pp. 1124–1132, 2014.
View at: Publisher Site | Google Scholar
Z. Yang, J. Qin, L. Zhao et al., “Host sorbitol and bacterial sorbitol utilization promote Clostridioides difficile infection in inflammatory bowel disease,” Gastroenterology, vol. 164, no. 7, pp. 1189–1201.e13, 2023.
View at: Publisher Site | Google Scholar
H. G. Hers, “The mechanism of the transformation of glucose in fructose in the seminal vesicles,” Biochimica et Biophysica Acta, vol. 22, no. 1, pp. 202-203, 1956.
View at: Publisher Site | Google Scholar
C.-H. Li, C.-T. Wang, Y.-J. Lin et al., “Long-term consumption of the sugar substitute sorbitol alters gut microbiome and induces glucose intolerance in mice,” Life Sciences, vol. 305, Article ID 120770, 2022.
View at: Publisher Site | Google Scholar
I.-K. Aggeli, A. Kapogiannatou, F. Paraskevopoulou, and C. Gaitanaki, “Differential response of cardiac aquaporins to hyperosmotic stress; salutary role of AQP1 against the induced apoptosis,” European Review for Medical and Pharmacological Sciences, vol. 25, no. 1, pp. 313–325, 2021.
View at: Publisher Site | Google Scholar
M. Olivera-Santa Catalina, M. Caballero-Bermejo, R. Argent et al., “Hyperosmotic stress induces tau proteolysis by caspase-3 activation in SH-SY5Y cells,” Journal of Cellular Biochemistry, vol. 117, no. 12, pp. 2781–2790, 2016.
View at: Publisher Site | Google Scholar
X. Lu, C. Li, Y.-K. Wang, K. Jiang, and X.-D. Gai, “Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction,” Oncology Letters, vol. 7, no. 6, pp. 1992–1996, 2014.
View at: Publisher Site | Google Scholar
M. Aslam and Y. Ladilov, “Emerging role of cAMP/AMPK signaling,” Cells, vol. 11, no. 2, Article ID 308, 2022.
View at: Publisher Site | Google Scholar
H. Li, Y. Zhang, M. Liu et al., “Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis,” Acta Pharmaceutica Sinica B, vol. 12, no. 1, pp. 228–245, 2022.
View at: Publisher Site | Google Scholar
A. Picchianti-Diamanti, F. R. Spinelli, M. M. Rosado, F. Conti, and B. Laganà, “Inhibition of phosphodiesterase-4 in psoriatic arthritis and inflammatory bowel diseases,” International Journal of Molecular Sciences, vol. 22, no. 5, Article ID 2638, 2021.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2024 Li Xiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

99

Downloads

62

Citations